Ipilimumab vs Tobramycin Sulfate
Ipilimumab vs Tobramycin Sulfate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Tobramycin Sulfate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Tobramycin Sulfate β Small molecule.